Vanda Pharmaceuticals | VNDA - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Akebia Therapeutics USD 229.55M 13.93M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
Heron Therapeutics USD 229.84M 861K 2026-06
Insmed USD 1.63B 20.75M 2026-06
J&J USD 59.77B 601M 2026-06
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
Ligand Pharmaceuticals USD 1.46B 591.7M 2026-06
Merck USD 36.68B 1.66B 2026-06
Minerva Neurosciences USD 83.1M 70.08M 2025-12
Moderna USD 5.82B 45M 2026-06
Novartis USD 26.61B 3.85B 2026-03
Pfizer USD 41.36B 1.46B 2026-06
PTC Therapeutics USD 2.62B 363.36M 2026-06
Puma Biotechnology USD 143.58M 7M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 31.52B 1.36B 2026-06
Takeda JPY 3.15T 59.77B 2026-06
Teva Pharmaceutical Industries USD 13.76B 50M 2026-06
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12
Veracyte USD 574.78M 52.6M 2026-06